A Study of LY2963016 Compared to Lantus in Adult Chinese Participants With Type 2 Diabetes Mellitus

The purpose of this study is to compare long-acting basal insulin analog LY2963016 to Lantus® in insulin naïve adult Chinese participants with Type 2 Diabetes Mellitus (T2DM) on 2 or more oral antihyperglycemic medications (OAMs). Participants will continue their OAMs throughout the study.


Study Type: Interventional  (Clinical Trial)
Estimated Enrollment: 530 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Prospective, Randomized, Open-Label Comparison of a Long-Acting Basal Insulin Analog LY2963016 to Lantus® in Adult Chinese Patients With Type 2 Diabetes Mellitus
Actual Study Start Date: March 22, 2018
Estimated Primary Completion Date: March 28, 2020
Estimated Study Completion Date: March 28, 2020

Arms:
- Experimental: LY2963016
- Active Comparator: Lantus®